Hepatitis E, IgM Antibodies. Screening

Clinical information

Diagnostic Utility:

This is the qualitative detection of IgM antibodies against the hepatitis E virus (HEV) and its determination is useful in:

• Identification of individuals in the acute phase of HEV infection or who have recently been exposed to the virus.

Method:

ELISA

Reference Values

Possible results: Positive and Negative

Diagnostic Algorithm:

Not applicable

Turnaround Time:

Maximum 30 working days.

Specimen information

Sample: Serum and/or plasma
Tube: Aliquots of 1-5 mL, plasma tubes with EDTA, sodium citrate, or heparin as anticoagulant and/or serum tubes with and without gel separator.
Minimum essential volume: 1ml

Stability:

• At room temperature: ≤ 4 days
• In refrigeration 2-8 ºC: ≤ 14 days
• Frozen sample equal to or below -20ºC: 10 years

Transport instructions: Preferably at room temperature and/or refrigerated if dealing with whole blood tubes and frozen if dealing with serum and/or plasma aliquots.

Reason for rejection: Samples inactivated by heat, jaundiced, hemolytic, and lipemic.

Administrative information

Test Description: Hepatitis E Antibodies IgM. Screening
Synonyms: anti-HEV IgM
Section: Transfusion Safety Laboratory
BST Rate: Check the updated rates here.

Profiles:

Test 0403 Hepatitis E, Antibodies IgM. Screening is requested with the profile:

References

• Inserts kits test MICROGEN DIAGNOSTIK recomWell HEV IgM

Quality

BST holds ISO 9001, ISO 14001, and OSHAS 18001 quality certifications, as well as the European Excellence 500+ seal. BST is accredited by CAT, JACIE-FACT, FACT-NETCORD, and EFI, and complies with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) guidelines.